Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harikrishna Nakshatri

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Breast Cancer Research : BCR|April 10, 2010
Radiation resistance in breast cancer: are CD44+/CD24-/proteosome low/PKH26+ cells to blame?Harikrishna Nakshatri
The Journal of Pathology|November 8, 2012
Role of AKT isotypes in breast cancerSunil Badve, Harikrishna Nakshatri
Expert Reviews in Molecular Medicine|March 6, 2009
FOXA1 in breast cancerHarikrishna Nakshatri, Sunil Badve
Expert Opinion on Therapeutic Targets|March 22, 2007
FOXA1 as a therapeutic target for breast cancerHarikrishna Nakshatri, Sunil Badve
The Lancet. Oncology|January 10, 2012
Breast-cancer stem cells-beyond semanticsSunil Badve, Harikrishna Nakshatri
Cancers|January 17, 2020
Systemic Actions of Breast Cancer Facilitate Functional LimitationsRuizhong Wang, Harikrishna Nakshatri
Current Problems in Cancer|November 14, 2002
NF-kappaB and breast cancerHarikrishna Nakshatri, Robert J Goulet
BMC Cancer|December 19, 2014
PROGgeneV2: enhancements on the existing databaseChirayu Pankaj Goswami, Harikrishna Nakshatri
Journal of Clinical Bioinformatics|January 1, 2013
PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available dataChirayu Pankaj Goswami, Harikrishna Nakshatri
Cancer Research|September 28, 2022
Modeling Preclinical Cancer Studies under Physioxia to Enhance Clinical TranslationAdedeji K Adebayo, Harikrishna Nakshatri
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Breast Cancer Research : BCR|April 10, 2010
Radiation resistance in breast cancer: are CD44+/CD24-/proteosome low/PKH26+ cells to blame?Harikrishna Nakshatri
The Journal of Pathology|November 8, 2012
Role of AKT isotypes in breast cancerSunil Badve, Harikrishna Nakshatri
Expert Reviews in Molecular Medicine|March 6, 2009
FOXA1 in breast cancerHarikrishna Nakshatri, Sunil Badve
Expert Opinion on Therapeutic Targets|March 22, 2007
FOXA1 as a therapeutic target for breast cancerHarikrishna Nakshatri, Sunil Badve
The Lancet. Oncology|January 10, 2012
Breast-cancer stem cells-beyond semanticsSunil Badve, Harikrishna Nakshatri
Cancers|January 17, 2020
Systemic Actions of Breast Cancer Facilitate Functional LimitationsRuizhong Wang, Harikrishna Nakshatri
Current Problems in Cancer|November 14, 2002
NF-kappaB and breast cancerHarikrishna Nakshatri, Robert J Goulet
BMC Cancer|December 19, 2014
PROGgeneV2: enhancements on the existing databaseChirayu Pankaj Goswami, Harikrishna Nakshatri
Journal of Clinical Bioinformatics|January 1, 2013
PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available dataChirayu Pankaj Goswami, Harikrishna Nakshatri
Cancer Research|September 28, 2022
Modeling Preclinical Cancer Studies under Physioxia to Enhance Clinical TranslationAdedeji K Adebayo, Harikrishna Nakshatri
Pageof 16